The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates

Journal:
eLife
Published:
DOI:
10.7554/elife.64815
Affiliations:
7
Authors:
15
Institutions Authors Share
University of Minnesota (UMN), United States of America (USA)
8.000000
0.53
The University of Iowa (UI), United States of America (USA)
4.000000
0.27
New York Blood Center (NYBC), United States of America (USA)
2.000000
0.13
University of Texas Medical Branch (UTMB), United States of America (USA)
1.000000
0.07